The Economic Times Glenmark Pharma may outperform amid market correction; technicals turn positive: Ruchit Jain Aris March 24, 2026 Originally published by The Economic Times https://economictimes.indiatimes.com/markets Continue Reading Previous: US bans new foreign-made consumer internet routersNext: Eyecare biotech jumps 19% after stablecoin-focused rebrand Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. Related Stories The Economic Times India's hidden semiconductor advantage: What's next in the chip journey? Aris July 2, 2026 The Economic Times Bitcoin trades near $60,000, logs weakest month since June 2022 amid ETF outflows Aris July 2, 2026 The Economic Times SBI Mutual Fund planning IPO launch on July 13, to raise $1.2 billion Aris July 2, 2026